In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells--clinical implications

Leukemia. 2008 Nov;22(11):2115-8. doi: 10.1038/leu.2008.92. Epub 2008 May 1.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neoplasm / immunology*
  • Antibodies, Neoplasm / metabolism
  • Case-Control Studies
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Humans
  • Immunoenzyme Techniques
  • Leukemia, Plasma Cell / genetics
  • Leukemia, Plasma Cell / immunology*
  • Leukemia, Plasma Cell / metabolism
  • Multiple Myeloma / genetics
  • Multiple Myeloma / immunology*
  • Multiple Myeloma / metabolism
  • Paraproteinemias / genetics
  • Paraproteinemias / immunology*
  • Paraproteinemias / metabolism
  • Receptors, Laminin / genetics
  • Receptors, Laminin / immunology*
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / immunology*

Substances

  • Antibodies, Neoplasm
  • RPSA protein, human
  • Receptors, Laminin
  • Ribosomal Proteins